Ameriprise Portfolio holdings
Ameriprise Financial, Inc., founded in 1894 as Investors Syndicate and headquartered in Minneapolis, Minnesota, is a leading financial services firm specializing in wealth management, financial planning, and insurance, managing hundreds of billions in assets for individual and institutional clients. Evolving from its roots in investment certificates, it now offers a comprehensive suite of services, including retirement planning, annuities, mutual funds, and advisory solutions, delivered through a network of over 10,000 financial advisors across the U.S. Known for its client-first approach, Ameriprise became independent in 2005 after spinning off from American Express, focusing on personalized advice and robust digital tools to compete in a crowded market. With a strong emphasis on long-term relationships and financial security, Ameriprise has grown into a trusted name in the retail investment and insurance sectors.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares Russell 1000 Growth ETF
IWF
|
+$915M |
| 2 |
Vanguard Russell 1000 Growth ETF
VONG
|
+$576M |
| 3 |
NVIDIA
NVDA
|
+$355M |
| 4 |
BNY
Bank of New York Mellon
BNY
|
+$321M |
| 5 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$273M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Broadcom
AVGO
|
+$991M |
| 2 |
Cigna
CI
|
+$435M |
| 3 |
Berkshire Hathaway Class B
BRK.B
|
+$432M |
| 4 |
Medtronic
MDT
|
+$379M |
| 5 |
Alphabet (Google) Class C
GOOG
|
+$376M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 23.3% |
| 2 | Financials | 10.89% |
| 3 | Healthcare | 10.04% |
| 4 | Industrials | 8.79% |
| 5 | Consumer Discretionary | 7.55% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
3301
MPLX
MPLX
$59.7B
| $611K | ﹤0.01% |
16,648
+206
| +1% | +$7.4K |
|
3302
Allogene Therapeutics
ALLO
$694M
| $611K | ﹤0.01% |
190,295
+55,704
| +41% | +$158K |
|
3303
Veracyte
VCYT
$3.8B
| $610K | ﹤0.01% |
22,179
-146,910
| -87% | -$3.55M |
|
3304
Invesco Municipal Trust
VKQ
$551M
| $608K | ﹤0.01% |
63,797
-2,947
| -4% | -$26K |
|
|
CBAY
3305
DELISTED
Cymabay Therapeutics
CBAY
| $607K | ﹤0.01% |
+25,711
| New | +$458K |
|
3306
iShares MSCI World ETF
URTH
$8.27B
| $607K | ﹤0.01% |
4,563
-1,086
| -19% | -$135K |
|
3307
Oaktree Specialty Lending
OCSL
$1.14B
| $607K | ﹤0.01% |
29,722
+2,867
| +11% | +$56.6K |
|
3308
JPMorgan BetaBuilders Japan ETF
BBJP
$18.8B
| $606K | ﹤0.01% |
11,519
-1,100
| -9% | -$55.9K |
|
|
PLL
3309
DELISTED
Piedmont Lithium
PLL
| $606K | ﹤0.01% |
21,460
+1,449
| +7% | +$42.6K |
|
3310
BayCom
BCML
$333M
| $605K | ﹤0.01% |
25,663
+1,941
| +8% | +$40.7K |
|
3311
Global X SuperDividend ETF
SDIV
$1.21B
| $602K | ﹤0.01% |
26,709
-732
| -3% | -$15.7K |
|
3312
BCB Bancorp
BCBP
$161M
| $599K | ﹤0.01% |
46,596
+15,786
| +51% | +$180K |
|
|
QIPT
3313
DELISTED
Quipt Home Medical
QIPT
| $597K | ﹤0.01% |
117,263
-17,749
| -13% | -$85K |
|
3314
Nokia
NOK
$52.3B
| $594K | ﹤0.01% |
173,652
-80,149
| -32% | -$272K |
|
3315
Lucid Motors
LCID
$2.77B
| $594K | ﹤0.01% |
14,106
-10,888
| -44% | -$489K |
|
3316
BlackRock Income Trust
BKT
$341M
| $593K | ﹤0.01% |
48,658
-71,246
| -59% | -$814K |
|
3317
Spero Therapeutics
SPRO
$73M
| $592K | ﹤0.01% |
402,963
-60,678
| -13% | -$72.3K |
|
3318
Ooma
OOMA
$604M
| $592K | ﹤0.01% |
55,165
-8,533
| -13% | -$96.9K |
|
3319
Invesco Food & Beverage ETF
PBJ
$107M
| $592K | ﹤0.01% |
12,903
-25,220
| -66% | -$1.09M |
|
3320
Hawaiian Electric Industries
HE
$2.14B
| $589K | ﹤0.01% |
41,496
-11,266
| -21% | -$146K |
|
3321
Nuveen New York AMT-Free Quality Municipal Income Fund
NRK
$912M
| $589K | ﹤0.01% |
55,890
+678
| +1% | +$6.61K |
|
3322
CION Investment
CION
$374M
| $588K | ﹤0.01% |
51,988
+2,315
| +5% | +$24.6K |
|
3323
iShares Asia 50 ETF
AIA
$4.73B
| $588K | ﹤0.01% |
10,138
-48,729
| -83% | -$2.75M |
|
|
KIO
3324
KKR Income Opportunities Fund
KIO
$457M
| $585K | ﹤0.01% |
+46,553
| New | +$554K |
|
|
CDMO
3325
DELISTED
Avid Bioservices, Inc. Common Stock
CDMO
| $585K | ﹤0.01% |
89,990
-206,973
| -70% | -$1.33M |
|
Similar funds
Ameriprise's Q4 2023 Portfolio in Review
As of Q4 2023, Ameriprise held 4,040 positions worth $334B, up 9.7% from $305B the previous quarter. Its ten largest holdings account for 17% of the portfolio.
Ameriprise's Q4 2023 filing shows 156 new, 1,686 increased, 1,943 reduced and 146 closed positions. Its largest new stake was Pacer US Small Cap Cash Cows 100 ETF: 647,103 shares worth $31M. The largest sale was Broadcom, an estimated $991M.
By sector, the portfolio is most concentrated in Technology at 23% of assets, up from 23% a quarter earlier, followed by Financials and Healthcare.
- Ameriprise's largest Q4 2023 buy was Pacer US Small Cap Cash Cows 100 ETF: 647,103 shares worth $31M.
- Ameriprise added most to iShares Russell 1000 Growth ETF in Q4 2023, an estimated $915M increase.
- Ameriprise's biggest Q4 2023 reduction was Broadcom, cutting an estimated $991M.
- Ameriprise fully exited Activision Blizzard in Q4 2023, selling an estimated $374M.
- Ameriprise's ten largest holdings make up 17% of its $334B portfolio in Q4 2023.
- Ameriprise opened 156 new positions and closed 146 in Q4 2023.
- Ameriprise's portfolio value rose 9.7% quarter-over-quarter to $334B.
Based on Ameriprise's 13F filing for Q4 2023, filed 14 Feb 2024.